Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
North America is the largest supplier of Blood Product, with production revenue market share about 60%, and the sales market share is 40% in 2015. That is to say, there are a large number of exports in North America, while North America also is the largest consumption region.
Europe, following North America, takes production revenue market share of 20% and the sales market share over 20%. China is an important market of Blood Product in Asia, accounting for 9% production revenue market share and 14% sales revenue market share of global market.
Japan has equal production revenue market share and sales revenue market share nearly. The local production can meet most local demand, and there is a small amount of imports.

According to this study, over the next five years the Blood Product market will register a 10.6% CAGR in terms of revenue, the global market size will reach USD 47800 million by 2024, from USD 26100 million in 2019. In particular, this report presents the global revenue market share of key companies in Blood Product business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Blood Product market by product type, application, key companies and key regions.

This study considers the Blood Product value generated from the sales of the following segments-

Segmentation by product type- breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Albumin
Immune Globulin
Others
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Immunity
Therapy
Surgery
Other

This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
Baxter
CSL
Grifols
Octapharma
BPL
Kedrion
Mitsubishi Tanabe
CBOP
RAAS
Hualan Bio

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Blood Product market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Blood Product market by identifying its various subsegments.
Focuses on the key global Blood Product players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Blood Product with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Blood Product submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.